Switchovers to Repetabs formula of beta-agonist bronchodilator accounted for one-third of all Proventil tablet sales in 1988, not one-third of the asthma drug's total volume, as reported in the March 20 issue of "The Pink Sheet" (T&G-6). Repetabs sales represent about 6% of total $ 100 mil. Proventil sales. The product is a b.i.d. formulation. Proventil inhaler volume is roughly $ 59 mil., followed in order by $ 19 mil. for solution form, $ 13 mil. for tablets and roughly $ 3 mil. for Proventil syrup.
You may also be interested in...
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Tests used to detect cytomegalovirus in organ transplant patients may face an easier path to market under a proposed rule that the US Food and Drug Administration released on 18 September. See what the regulatory agency said about it here.
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.